Washington Wheat Calls For Bipartisan Action

WAWG and WGC Calls for an Immediate Short Term Extension, Farmers Need Stability and Certainty

DSPEC selected and qualified as a GSA MOBIS contractor to provide management and consulting services that improve federal agency performance and help meet the government's mission goals.

One hour course accredited by AIA and IDCEC for architects, interior designers, planners, and others involved in the design process.

Mr. Domingue has been recognized has been recognized for excellence in business.

With teams in Lebanon, United States, Saudi Arabia, United Arab Emirates and Kuwait, Eurisko Mobility successfully implements Work From Home strategy in order to keep delivering enterprise mobile, web, IoT products to local and international clients

Dr. Frese has always harbored an interest in science

Mr. Albino has been endorsed by Marquis Who's Who as a leader in the writing industry

Sept. 15 – Nov 5, 2019 - Opening Reception: Friday Oct. 4, 2019, 6:30–8:00 pm. Light hors d'oeuvres will be served.

Anthony Ziccardi Studios has been voted Sussex County's Best Photo Studio for eight consecutive years

Ms. Osborne is the owner of Moments of the Heart Photography

Mr. Cupp was nominated for a Star on the Latin American Walk of Fame in Mexico City in 2015

Ms. Rios is the director and owner of Jewel of Art Dance Studio

Book Becomes #1 International Best Seller

BiCupid, a popular bisexual dating site, has been getting a lot of positive reviews of late and it has managed to cross the prestigious 2 million user count.

Local Artist Cedric Chevalley Holds an Event to Show the Power of Community

Reform-a-nation Campaign/Docuseries Focuses on Injustice & Wrongful Convictions Like Anand Jon Alexander and Others in California and Beyond

Birdsong offers eight thousand unique, engaging content experiences, including video chat, music, classic tv shows, videos, travel, and fun brain fitness exercises and memory games.

How God Used a Terminal Diagnosis to Turn a Family and a Football Team into Champions!

An explicit collection of erotic short stories has just been released by author and sexuality podcaster Lexi Sylver.

BHS, Inc. has created a solution for dealers and end-users who would like to experience the manufacturer's products in person, but can't travel to the company's St. Louis headquarters.

Next-generation LED dimmers and drivers making their debut

Bill's Equipment & Supply has added several brand-new items to their wide array of rental equipment in the Colorado Springs area for the Spring season!

The OCMX™ is pleased to announce the listing of Blue Biofuels, Inc. to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

West Va. to Implement Alternative Absentee Voting Method

1 in 5 Americans Have Invisible Learning Disabilities and they ALL Deserve to VOTE in 2020

Online summit for birth healing practitioners to help moms heal more completely after birth

Item by Item (IBI) – www.itembyitem.co - announced today the release of Microsoft Dynamics 365 (D365) Commerce online training curriculum.

Ms. Penn is a pioneering figure in applied merchandising techniques for auction marketplaces

Held at the AllBright Collective in West Hollywood, Guests at Chella Beauty's Exclusive Event Enjoyed Pampering, Mingling and a Chance to be the First to Experience Chella's New Palette.

Fight clubs and fashion designers are betting on "The Bronze Bomber" worn by Deontay Wilder, designed by Cosmo & Donato.

Built on Guided Journeys, the Solutions Enable Digital Transformation by Making Complex Processes Easier to Manage

Sustainability, the Catchword of Today and Tomorrow

bestmarijuanaguide.com, the premier online directory for cannabis products, suppliers, and dispensaries has announced it launch on the morning of April 1st, 2020.

Bid Desk Publishes Online List to Help Consumers Create Healthier Work from Home and Homeschooling Spaces

Many homeowners struggling financially in the coronavirus pandemic worry mortgage servicers will require them to repay mortgage bills all at once.

(Bloomberg) -- Kingsoft Cloud Holdings Ltd. rose 40% in the first major trading debut by a Chinese company since the accounting scandal at Luckin Coffee Inc.The affiliate of Hong Kong-listed Kingsoft Corp. raised $510 million in its initial public offering, pricing its shares at the midpoint of a $16 to $18 targeted range. The shares closed at $23.84 in New York trading Friday, giving the company a market value of $4.77 billion.The Beijing-based cloud computing service company, which had marketed 25 million shares, increased the sale to 30 million American depositary shares.The IPO is the biggest by a Chinese company in the U.S. this year, according to data compiled by Bloomberg. It’s a tricky time for Chinese companies listing in the U.S. after the poster child of Chinese startups, Luckin, was accused of accounting fraud. Luckin’s shares had fallen 74% from its IPO price last year when trading of its stock was suspended in April.Read: Luckin Coffee Scandal Deals Blow to China Inc.’s Reputation“Given the context regarding China ADR, it’s actually good for quality companies,” Henry He, Kingsoft Cloud’s chief financial officer, said in an interview Friday evening in Hong Kong. “The capital has to be deployed and quality long-only investors will pay more attention to quality companies like us.”Tense MomentFinancial performance of Kingsoft Cloud has been consolidated with its Hong Kong-listed parent since its inception and there are publicly available track records for investors to analyze, he added.Its IPO comes at a tense moment for the U.S.-China relationship, after President Donald Trump and Chinese state media have exchanged heated criticisms regarding the origin of coronavirus responsible for the pandemic that has killed more than 269,000 and brought much of the world’s economy to a standstill.China Liberal Education Holdings Ltd., a Beijing-based educational company, fell 18% in its U.S. trading debut Friday after raising $8 million in its IPO. A third company that went public Friday, Ayala Pharmaceuticals Inc., rose 0.2% after its $55 million offering.Kingsoft Cloud is the third-biggest cloud services provider in China by revenue with a market share of 5.4%, according to its filings with the U.S. Securities and Exchange Commission. Last year, it lost $160 million on revenue of $568 million. Its chairman, Lei Jun, was a co-founder of smartphone-maker Xiaomi Corp., which will own about a 14% stake in the company after the offering, according to the filings.The offering was led by JPMorgan Chase & Co., UBS Group AG, Credit Suisse Group AG and China International Capital Corp. The company’s shares are trading on the Nasdaq Global Select market under the symbol KC.(Updates with closing share price in second paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

The latest data analyzed by The Block Research shows that bitcoin miners made 8% more revenue in April as compared to March, thanks to a gradual recovery in bitcoin’s price.The post Bitcoin miners made $412.5 million in revenue during April, new data indicates appeared first on The Block.

Bitcoin is growing against the entire crypto market, adding 3% in the last 24 hours. The first cryptocurrency is not only above $9K but is close to reaching $10K.

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Does history repeat? Many of us, no doubt, remember the crash of the doc.com bubble back in 2000, and at least one analyst sees that pattern repeating before our eyes. Will Meade, who built his reputation in stock analysis with Goldman Sachs, believes that the current rally is only temporary, and that the markets are likely to fall again in 2H20 – by as much as 40%.Meade points that, like in 2000, we have the risk and uncertainty of a Presidential election coming up, and then adds, “The NASDAQ in 2000 did a similar bear market bounce as stocks this year — dropped 40%, then bounced 42% off the bottom retracing 61.8% of its drop. It stalled then fell 43%, making a new low four months later.” If Meade is right, then the true market bottom is due to hit us in late July or early September.The analyst is not all doom and gloom, however. While he is predicting bad news and tough times for the stock markets, he also points out that investors can act now to buffer their personal positions. His advice: move to liquid assets and build a cash savings buffer.Shoring up the savings account is only part of a strong defensive strategy. Investors can also shift their portfolio toward dividend stocks, relying on the steady income from the dividend payments to compensate for lower share price appreciation.We’ve used TipRanks database to find three high-yielding stocks that offer reliable payments – and all three have gotten the thumbs up from Maxim analyst Michael Diana.Ellington Financial, Inc. (EFC)We’ll start in the financial sector, with a small-cap company in the mortgage finance niche. Ellington operates as an investor, putting money into consumer loans, equity investments, mortgage backed securities, and both residential and commercial mortgages. It’s a standard portfolio for a mortgage-focused real estate investment trust.As an REIT, Ellington naturally offers a high dividend. REITs are required to a return a high percentage of profits to investors, and dividends are a sure way to comply with that regulatory provision. In response to the COVID-19 epidemic, and consequent economic damage, Ellington had to reduce its monthly payment starting with the April 29 payout. However, the company is maintaining a 54% payout ratio – returning more than half of earnings to investors. The 8-cent per share payment annualized to 96 cents, and offers investors a yield of 10%.Right now, the Fed’s key interest rate is down to the 0 to 25 basis point range, and Treasury bonds are yielding less than 1%. Even among dividend stocks, the average yield is just 2%. So, EFC’s 10% dividend yield is a fantastic return. Looking ahead, the company is expected to show 40 cents per share in earnings for Q1, more than enough to maintain the new monthly dividend.Maxim’s Michael Diana has tagged EFC as a ‘top pick,’ particularly noting the company’s strong management team: "Managing an mREIT even in 'normal' times is a difficult task, as the manager must balance leverage, prepayment protection, interest income, hedging, and diversity of financing sources to position the investment portfolio to withstand unexpected shocks without giving up too much income. When an unexpected shock does occur, crisis management skills are required to dynamically hedge and reposition the portfolio. We have followed EFC longer than any other analyst and, in our view, EFC management possesses all of these skills."Diana puts an $18 price target on EFC shares, implying a whooping 82% upside potential that fully supports his Buy rating. (To watch Diana’s track record, click here)Wall Street agrees with Diana’s assessment here. The analyst consensus on this stock is a Strong Buy, and it is unanimous, based on 4 Buy reviews set in recent weeks. Shares are selling at a comfortable entry point, just $9.87, and the average price target of $14.38 suggests room for a robust 46% upside growth this year. (See Ellington stock analysis on TipRanks)AGNC Investment (AGNC)Based in the Maryland suburbs of Washington DC, AGNC is another REIT. The company’s portfolio is centered on residential mortgage-backed securities, but with a twist. Most of AGNC’s portfolio investments are guaranteed by the US government. The company’s portfolio includes $70.7 billion in such agency-supported securities, out of a total value of $93 billion.AGNC reported fiscal Q1 earnings at the end of April, and beat the forecast on EPS. Per-share earnings came in at 57 cents, based on $65 million in net interest income. The income interest figure is down significantly from the previous quarter, reflecting the economic troubles caused by the COVID-19 pandemic. On a positive note, AGNC’s cash holdings increased 55% in the first quarter, reaching $1.29 billion by March 31.A solid cash position and safe guarantees on the portfolio make AGNC an attractive investment, and the reliable monthly dividend adds icing to that cake. Like EFC above, AGNC lowered its monthly payment in Q1. The new payment is 12 cents per share per month, which annualized to $1.44 and gives a strong yield of 11.5%. At 63.2%, the payout ratio shows that the dividend is easily sustainable at current income levels – and has room to raised back to previous rates when conditions warrant.Diana is bullish on this stock and upgrades his rating from Hold to Buy. The analyst noted, "While turmoil in the mortgage markets at the end of March resulted in losses and lower book values for all mREITs, AGNC was able to meet all of its margin calls and, importantly, take relatively fewer realized losses, and therefore retain more earnings power post-turmoil. This is why we believe the dividend, currently yielding 11.7% (vs. ~5% for peers) is safe."Along with the Buy rating, Diana gives AGNC a $15 price target, indicating a potential for 20% upside appreciation in the coming 12 months.The analysts are somewhat cautious on AGNC, a sentiment caught by the 8 to 3 split between Buy and Hold reviews. The consensus rating on the stock remains a Moderate Buy, while the $14.53 average price target implies a 14% upside potential. (See AGNC stock analysis on TipRanks)Manhattan Bridge Capital (LOAN)Last on our list is a NYC-based micro-cap lending company, Manhattan Bridge Capital. The company offers short-term financing and collateralized loans. Typical collateral includes real estate and tradeable stock, and the loans are usually used as first mortgages. LOAN originates, services, and manages its loan portfolio, and most of its customers are professional real estate investors and developers.The coronavirus epidemic has hurt real estate development and construction – exactly the type of projects that LOAN finances – in general, but that hit has been especially hard in New York City. At both the State and City levels, lockdown restrictions have been severe, and the mortgage loan environment is described by Diana as ‘challenging.’On a positive note, LOAN has covered its quarterly dividend payment, despite lower Q1 earnings. At 11 cents per share, the quarterly dividend annualized to 44 cents and offers investors a yield of 10.8%. Again, this compares favorably to most investment return yields out there.The high dividend yield alone makes this an attractive investment opportunity, but Diana also points out the stability of Manhattan Bridge’s portfolio, writing, “LOAN has never had to foreclose on a property and has never experienced a loan default.”With the stable portfolio in mind, Diana goes on to say, “We believe LOAN deserves to trade at a P/E premium to [peers] because of its: 1) lower leverage; 2) higher profitability; 3) better credit quality; 4) lower earnings volatility; and 5) dividend growth (which is possible in 2021, in our view, if the environment improves and stabilizes).”Diana’s $6 price target on the stock implies a healthy 46% one-year upside potential, and fully backs his Buy rating on the stock. Diana’s is the only recent Wall Street review of this stock – but should his thesis prove correct, expect LOAN to attract both stock analysts and investors in the near future. It offers a low cost of entry with a high potential return – an unbeatable combination. (See LOAN stock analysis on TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

GitHub on Wednesday announced two new security features designed to help developers identify vulnerabilities and potential secrets in their code.

The company announced several new products at its Satellite virtual conference, including ones aimed at helping customers write and consume more secure code.

read more

A large-scale attack campaign has targeted over 900,000 WordPress websites through vulnerabilities in plugins and themes, WordPress security company Defiant revealed this week.

read more

Researchers have found another vulnerability in software made by Schneider Electric that is similar to the one exploited by the notorious Stuxnet malware.

read more

A couple of Salt vulnerabilities addressed last week were abused over the weekend to hack Algolia’s infrastructure, the search-as-a-service startup revealed.

read more

Cisco Patches High Severity Vulnerabilities in Adaptive Security Appliance (ASA) and Firepower Threat Defense (FTD)

Cisco this week released security updates to address more than 30 vulnerabilities in various products, including 12 high severity flaws impacting Adaptive Security Appliance (ASA) and Firepower Threat Defense (FTD).

read more

Samsung this week released its May 2020 set of security updates for Android smartphones, which includes a patch for a critical vulnerability impacting all of its devices since 2014. 

read more

Threat actors are actively targeting a vulnerability in the Elementor Pro plugin for WordPress to compromise websites, WordPress security company Defiant warned this week.

read more

Motorcycle Rally Grows

Biker Next is Dating VIP's latest club that seeks to bring together everyone who's interested in biking - feel the wind and the open road with your partner!